Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Med Mol Morphol ; 54(2): 181-186, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33113037

RESUMEN

Mitochondrial cardiomyopathy can be described as a condition characterized by abnormal heart-muscle structure and/or function, secondary to mutations in nuclear or mitochondrial DNA. Its severity can range from subclinical to critical conditions. We presented three cases of mitochondrial cardiomyopathy with m.3243A > G mutation and compared the clinical manifestations with the histological findings for each of these cases. All cases showed cardiac hypertrophy, juvenile-onset diabetes mellitus, and hearing loss. Case 1 (43-year-old male) showed less cardiac involvement and shorter duration of mitochondrial disease-related symptoms than case 2 (67-year-old female) and case 3 (51-year-old male), who showed the most advanced cardiac condition and longest duration from the manifestation of heart failure. The histological findings revealed that cardiomyocytes from case 1 showed no hypertrophy and mitochondrial degeneration in electron microscopy. Alternatively, cases 2 and 3 showed hypertrophy in their cardiomyocytes, and mitochondrial degeneration (e.g. onion-like lesions, swollen cristae, and lamellar bodies) was most apparent in case 3. These results suggested that mitochondrial degeneration, as evaluated by electron microscopy, might be correlated with impaired heart function in patients with mitochondrial cardiomyopathy.


Asunto(s)
Cardiomiopatías/genética , ADN Mitocondrial/genética , Sordera/genética , Diabetes Mellitus/genética , Mitocondrias/patología , Enfermedades Mitocondriales/genética , Mutación , Adulto , Anciano , Cardiomiopatías/diagnóstico , Cardiomiopatías/patología , Sordera/diagnóstico , Sordera/patología , Diabetes Mellitus/diagnóstico , Diabetes Mellitus/patología , Femenino , Humanos , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Mitocondrias/ultraestructura , Enfermedades Mitocondriales/diagnóstico , Enfermedades Mitocondriales/patología , Síndrome
2.
Chem Pharm Bull (Tokyo) ; 63(2): 117-21, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25748782

RESUMEN

Newly identified cyclic sulfoxides-garlicnins K1 (1), K2 (2), and H1 (3)-were isolated from the acetone extracts of the bulbs of garlic, Allium sativum. Garlicnin H1 (3) demonstrated potential to suppress tumor cell proliferation by regulating macrophage activation. The structures of garlicnins K1 and K2, 3,4-dimethyl-5-allyl-tetrahydrothiophen-2-one-S-oxides, and the structure of garlicnin H1, 3-carboxy-3-hydroxy-4-methyl-5-allylsulfoxide-tetrahydrothiophen-2-(ethane-1,2-diol)-S-oxide were characterized by spectroscopic analysis.


Asunto(s)
Ajo/química , Sulfóxidos/química , Antígenos CD/análisis , Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/análisis , Antígenos de Diferenciación Mielomonocítica/metabolismo , Línea Celular , Ensayo de Inmunoadsorción Enzimática , Ajo/metabolismo , Humanos , Macrófagos/citología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Espectroscopía de Resonancia Magnética , Conformación Molecular , Extractos Vegetales/química , Raíces de Plantas/química , Raíces de Plantas/metabolismo , Receptores de Superficie Celular/análisis , Receptores de Superficie Celular/metabolismo , Sulfóxidos/aislamiento & purificación , Sulfóxidos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA